Common risk factors
|
Metaplasia
|
Atrophy
|
Dysplasia
|
Abnormal gastric biopsy
|
No pathological finding
|
Total
|
---|
Age (years)
|
≤ = 40
|
5 (2.3)
|
2 (1.0)
|
2 (1.0)
|
59 (27.4)
|
147 (68.3)
|
215
|
41–50
|
19 (15.3)
|
13 (10.5)
|
16 (12.9)
|
16 (12.9)
|
60 (48.4)
|
124
|
51–60
|
24 (19.5)
|
22 (17.9)
|
9 (7.3)
|
16 (13.0)
|
52 (42.3)
|
123
|
≥ = 61
|
41 (33.3)
|
37 (30.1)
|
19 (15.4)
|
12 (9.7)
|
14 (11.4)
|
123
|
Sex
|
Female
|
52 (13.1)
|
41 (10.3)
|
32 (8.1)
|
78 (19.6)
|
194 (48.9)
|
397
|
Male
|
37 (19.7)
|
33 (17.5)
|
14 (7.4)
|
25 (13.3)
|
79 (42.0)
|
188
|
H. pylori infection
|
83 (17.7)
|
68 (14.5)
|
42 (8.9)
|
52 (11.1)
|
224 (47.8)
|
469
|
Smoking
|
20 (17.8)
|
17 (15.2)
|
9 (8.0)
|
16 (14.3)
|
50 (44.6)
|
112
|
NSAID use
|
13 (7.5)
|
11 (6.3)
|
6 (3.5)
|
27 (15.6)
|
116 (67.0)
|
173
|
Aspirin
|
8 (9.1)
|
13 (14.8)
|
6 (6.8)
|
15 (17.0)
|
46 (52.3)
|
88
|
Addiction (opium and/or methamphetamine)
|
35 (24.0)
|
30 (20.5)
|
17 (11.6)
|
19 (13.0)
|
45 (30.8)
|
146
|
Alcohol consumption
|
6 (12.0)
|
6 (12.0)
|
3 (6.0)
|
8 (16.0)
|
27 (54.0)
|
50
|
- NSAID, nonsteroidal anti-inflammatory drug